The present invention generally relates to the field of blood treatment. More particularly, the invention relates to an ex vivo method for treating an immunological dysfunction of blood. The invention also relates to an ex vivo method for removing toxic or inflammatory compounds from blood plasma and/or supplementing blood plasma with immunologically active compounds. The methods of the invention comprise the steps of extracorporeally separating at least part of the plasma from the blood and conducting the separated plasma through a plasma-permeable hollow fiber filter with immune cells located thereon such that the plasma comes into contact with the immune cells. The invention also relates to the use of a plasma-permeable hollow fiber filter with immune cells located thereon for the ex vivo treatment of an immunological dysfunction of blood. Finally, the present invention relates to the use of a plasma-permeable hollow fiber filter with immune cells located thereon for removing toxic or inflammatory compounds from blood plasma and/or supplementing blood plasma with immunologically active compounds.

The present invention provides for a method and apparatus for inserting and using dermal interstitial sensors in, for example, an analyte monitoring system, and for injecting active pharmaceutical ingredients, a bio-artificial organ device, and detection of a protein biomarker.

A system (200) for supporting a patient organ can include a primary circuit (212b), a secondary circuit (212a), and a controller (214). The primary circuit can include an inlet configured to connect to the patient (54), an outlet configured to connect to the patient, and a primary pump (206a). The secondary circuit can be connected to the primary blood circuit and can include an enclosure (202) configured to support an organ (50) therein in a blood flow, a secondary pump, a gas transfer unit (208), and a secondary sensor (238a). The controller can be configured to operate the gas transfer unit based on the secondary sensor signal. The organ may be a bio-engineered organ. In an example, the organ is a liver and operates to perform functions of a liver in place of or in support of the liver of the patient.

Disclosed are apparatus and methods for blood and other biological fluid purification using a membrane with cell containing vascular channel systems and filtration channel systems. Also disclosed are methods of making the apparatus as well as methods of making membranes.

An exemplary implantable device and an exemplary method for using the same can be provided. Such exemplary implantable device can comprise a mechanically flexible structure configured for a subdermal implantation, cell reservoirs (i) encased within the mechanically flexible structure, and (ii) configured to house engineered cells for secreting therapeutic peptides therein, integrated circuit (IC) chips including sensing and actuating arrays configured to provide temporal-controlled and dose-controlled release of the peptides, and wireless communication components configured to facilitate a wireless data transmission and a wireless charging of the implantable medical device.

An EBDLR system includes a multi-layered bio purifier having a plurality of layers. Each layer includes a membrane, a first type of cells on a first side of the membrane in a first channel, and a second type of cells on a second side of the membrane in a second channel. The EBDLR includes a plasma separator to receive blood from a subject and separate a plasma component from the blood, a first reservoir to collect the plasma component, and a second pump to move the plasma component from the first reservoir to the multi-layered bio purifier. The multi-layered bio purifier distributes the plasma component into the first and second channels of each layer to purify the plasma component. The EBDLR includes a second reservoir to collect the purified plasma component and a third pump to infuse the purified plasma component from the second reservoir into the subject.

Disclosed are apparatus and methods for blood and other biological fluid purification using a membrane with cell containing vascular channel systems and filtration channel systems. Also disclosed are methods of making the apparatus as well as methods of making membranes.

A multi-layered bio purifier includes a plurality of layers. Each layer may include a membrane having a first side and a second side opposite the first side, a first channel formed on the first side, and a second channel formed on the second side. Further, each layer may include a first type of cells formed on the first side in the first channel and a second type of cells formed on the second side in the second channel. The multi-layered bio purifier includes a first manifold assembly to split incoming blood into the first channel and the second channel of the plurality of layers and a second manifold assembly to combine processed blood from the first channel and the second channel of the plurality of layers. The processed blood may include detoxified or purified blood.

A method of treating a subject with acute liver failure is disclosed. The method involves including an EBDLR system into the subject's blood circuit and passing blood through the EBDLR system, where the blood is continuously taken from the subject. Further, the method includes separating the blood into a plasma component and remainder using a plasma separator of the EBDLR system and then passing the plasma component into a bio purifier having a plurality of layers. Each layer may include hepatocytes on a first side of a membrane in a first channel, and endothelial cells on a second side of the membrane in a second channel. Furthermore, the method includes splitting the plasma component into the first channel and the second channel of the plurality of layers to purify the plasma component, restoring the blood by combining the purified plasma component and the remainder, and continuously returning the restored blood into the subject.

The present disclosure relates to devices, e.g, extracorporeal blood purification (EBP) devices, which comprise a cartridge or sorbent comprising a cellular membrane derived from a cell. The present disclosure also relates methods for removing or reducing a substance, e.g, an undesirable substance, from a fluid, e.g, a subject's blood, using the devices or EBP devices.